1. Home
  2. CDNA vs NABL Comparison

CDNA vs NABL Comparison

Compare CDNA & NABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$20.03

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo N-able Inc.

NABL

N-able Inc.

HOLD

Current Price

$3.40

Market Cap

945.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
NABL
Founded
1998
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
945.6M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
CDNA
NABL
Price
$20.03
$3.40
Analyst Decision
Buy
Buy
Analyst Count
6
5
Target Price
$28.00
$8.31
AVG Volume (30 Days)
733.8K
1.0M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$48,324,000.00
$511,430,000.00
Revenue This Year
$16.01
$11.04
Revenue Next Year
$11.31
$8.53
P/E Ratio
$409.60
N/A
Revenue Growth
18.93
9.71
52 Week Low
$10.96
$3.32
52 Week High
$23.24
$9.04

Technical Indicators

Market Signals
Indicator
CDNA
NABL
Relative Strength Index (RSI) 47.72 25.47
Support Level $16.63 N/A
Resistance Level $21.20 $5.22
Average True Range (ATR) 1.33 0.33
MACD -0.22 -0.23
Stochastic Oscillator 38.34 7.34

Price Performance

Historical Comparison
CDNA
NABL

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.

Share on Social Networks: